Very lucky to be joined by 2 special guests, Michael Behal and Joanna Stollings, for this rapid reaction episode discussing the ACORN trial, Cefepime v. Piperacillin-tazobactam in Adults Hospitalized with Acute Infection, published in JAMA in October 2023.
Michael and I highlight the background of antibiotic-associated AKI, review the trial methodology and results, dive into the supplement and talk about duration of treatment, empiric v. targeted treatment, have definitively answered this question or not, and much more.
Plus, Joanna Stollings makes a special appearance highlighting her experience on the research group while also discussing the logistics of this innovative trial design.

Leave a comment